Ascent Group’s Humana HUM Stock Holding History

Ascent Group’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-589	Closed	-$291K	–	475
2023 Q2	$291K	Buy	589 +158	+37%	+$79.5K	0.03%	382
2023 Q1	$209K	Buy	+431	New	+$213K	0.02%	456

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ascent Group's HUM Position: Q3 2023 in Review

Ascent Group sold out of Humana (HUM) in Q3 2023, closing a stake of 589 shares — an estimated $291K sold.

Ascent Group first reported a position in HUM in Q1 2023 and held it in 2 quarters. The position peaked at $291K in Q2 2023. 1,086 funds tracked by Wall St. Rank hold HUM as of Q3 2023.

Ascent Group reported no remaining Humana position as of Q3 2023 after selling out during the quarter.
Ascent Group sold 589 Humana shares in Q3 2023, an estimated $291K.
Ascent Group first reported a position in Humana in Q1 2023 and held it in 2 quarters.
Ascent Group's Humana position peaked at $291K in Q2 2023.
1,086 funds tracked by Wall St. Rank held Humana as of Q3 2023.

Based on Ascent Group's 13F filing for Q3 2023, filed 14 Nov 2023.